Acta Med. 2018, 61: 158-161

https://doi.org/10.14712/18059694.2018.136

Pharyngeal Papilloma: a Rare Non-Pulmonary Cause of Hemoptysis

Stamatis Katsenos, Melita Nikolopoulou

Department of Pneumonology, Army General Hospital of Athens, Athens, Greece

Received March 19, 2018
Accepted November 25, 2018

References

1. Bishop JA. Benign Neoplasms of the Larynx, Hypopharynx and Trachea. In: Thompson LDR, Bishop JA, eds. Head and Neck Pathology. Elsevier 2019: 122–37 e2.
2. Abramson AL, Steinberg BM, Winkler B. Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope 1987; 97: 678–85. <https://doi.org/10.1288/00005537-198706000-00005>
3. Donne AJ, Hampson L, Homer JJ, Hampson IN. The role of HPV type in recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2010; 74: 7–14. <https://doi.org/10.1016/j.ijporl.2009.09.004>
4. Reeves WC, Ruparelia SS, Swanson KI, Derkay CS, Marcus A, Unger ER. National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2003; 129: 976-82. <https://doi.org/10.1001/archotol.129.9.976>
5. Omland T, Akre H, Lie KA, Jebsen P, Sandvik L, Brøndbo K. Risk factors for aggressive recurrent respiratory papillomatosis in adults and juveniles. PLoS ONE 2014; 9: e113584. <https://doi.org/10.1371/journal.pone.0113584> <PubMed>
6. Silva L, Gonçalves CP, Fernandes AM, Damrose EJ, Costa HO. Laryngeal papillomatosis in children: The impact of the late recognition over evolution. J Med Virol 2015; 87: 1413–7. <https://doi.org/10.1002/jmv.24181>
7. Zhang Z, Chang M, Moreta-Sainz CM. Case Report: Pulmonary Papillomatosis in a Patient Presenting with Cough and Hemoptysis. Perm J 2015; 19: e125–7.
8. Papaspyrou G, Schick B, Papaspyrou S, Eivazi B, Al Kadah B. Retrospective analysis of laser vs other therapeutic modalities for laryngeal papillomatosis. European multicenter study. J BUON 2016; 21: 1274–8.
9. Castillo CG, Garcia EM, Duran MD, Mestre MS, Gras JR. Papillomas and laryngeal papillomatosis. Treatment with CO2 laser surgery. Our experience over 15 years. Acta Otorrinolaringol Esp 2010; 61; 422–7.
10. Avelino MA, Zaiden TC, Gomes RO. Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis. Braz J Otorhinolaryngol 2013; 79: 636–42. <https://doi.org/10.5935/1808-8694.20130114> <PubMed>
11. Mesolella M, Motta G, LaguardiaM, Galli V. Papillomatosis of the larynx: treatment with CO2 laser. B-ENT 2006; 2: 51–4.
12. Gerein V, Rastorguev E, Gerein J, Jecker P, Pfister H. Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up. Ann Otol Rhinol Laryngol 2005; 114: 463–71. <https://doi.org/10.1177/000348940511400608>
13. Ablanedo-Terrazas Y, Soda-Merhy A, Hernández-Palestina M, Ormsby CE, Reyes-Terán G. Intralesional cidofovir in severe juvenile respiratory papillomatosis. B-ENT 2012; 8: 197–202.
14. Rahbar R, Vargas SO, Folkman J, et al. Role of vascular endothelial growth factor-A in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2005; 114: 289–95.
15. Zeitels SM, Barbu AM, Landau-Zemer T, et al. Local injection bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective study. Ann Otol Rhinol Laryngol 2011; 120: 627-34. <https://doi.org/10.1177/000348941112001001>
16. Best SR, Mohr M, Zur KB. Systemic bevacizumab for recurrent respiratory papillomatosis: A national survey. Laryngoscope 2017; 127: 2225–9. <https://doi.org/10.1002/lary.26662> <PubMed>
17. Young DL, Moore MM, Halstead LA. The use of the quadrivalent human papilloma virus vaccine (Gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma. J Voice 2015; 29: 223–9. <https://doi.org/10.1016/j.jvoice.2014.08.003>
18. Mauz PS, Schäfer FA, Iftner T, Gonser P. HPV vaccination as preventive approach for recurrent respiratory papillomatosis – a 22-year retrospective clinical analysis. BMC Infect Dis 2018; 18: 343. <https://doi.org/10.1186/s12879-018-3260-0> <PubMed>
19. Makiyama K, Hirai R, Matsuzaki H. Gardasil vaccination for recurrent laryngeal papillomatosis in adult men: first report: changes in HPV antibody titer. J Voice 2017; 31: 104–6. <https://doi.org/10.1016/j.jvoice.2016.01.008>
20. Sullivan C, Curtis S, Mouzakes J. Therapeutic use of the HPV vaccine in Recurrent Respiratory Papillomatosis: A case report. Int J Pediatr Otorhinolaryngol 2017; 93: 103–6. <https://doi.org/10.1016/j.ijporl.2016.12.035>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive